Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 3, 2006, Pages 622-628

  Östör, Andrew J K ^a   Chilvers, Edwin R ^b   Somerville, Margaret F ^c   Lim, Anita Y N ^c   Lane, Suzanne E ^d   Crisp, Adrian J ^a   Scott, David G I ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Anti tumor necrosis factor therapy; Bronchiolitis obliterans organizing pneumonia; Infliximab; Interstitial lung disease; Rheumatoid arthritis; Usual interstitial pneumonia

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CEFOTAXIME; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ERYTHROMYCIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL ARTICLE; DIARRHEA; DISEASE EXACERBATION; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG FIBROSIS; MALE; NAUSEA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FATAL OUTCOME; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644699177     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ostor AJK, Crisp AJ, Somerville MF, Scott DGI. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. BMJ 2004;329:1266.
2. Vassallo R, Thomas CF. Advances in the treatment of rheumatic interstitial lung disease. Curr Opin Rheumatol 2004;16:186-91.
3. Willoughby J, Salejee I, Dellaripa P, et al. Screening for interstitial lung disease in recent onset rheumatoid arthritis [abstract]. Arthritis Rheum 2004;50 Suppl:1464.
4. Gochuico BR. Potential pathogenesis and clinical aspects of pulmonary fibrosis associated with rheumatoid arthritis. Am J Med Sci 2001;24:19-33.
5. Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 2002;61:517-21.
6. Ostor AJ, O'Gradaigh DR, Jenner JR. Methotrexate for rheumatoid arthritis: what should the patient be told? Rheumatology Oxford 2003;42:1576-8.
7. Bedrossian CW, Sussman J, Conklin RH, Kahan B. Azathioprine-associated interstitial pneumonitis. Am J Clin Pathol 1984;82:148-54.
8. Brown AL, Corris PA, Ashcroft T, Wilkinson R. Azathioprine-related interstitial pneumonitis in a renal transplant recipient. Nephrol Dial Transplant 1992;7:362-4.
9. McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461.
10. Balakrishnan C, Fernando M, Kalke S, Rae AM, Dasgupta B. Serious pulmonary events in patients on leflunomide [abstract]. Rheumatology Oxford 2001;40 Suppl 1:234.
11. Kamata Y, Nara H, Kamimura T, et al. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 2004;43:1201-4.
12. Maini R, St. Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 1999;354:1932-9.
13. Durez P, Nzeusseu A, Dufour JP, Devogelaer JP, Houssiau FA. Treatment of severe refractory rheumatoid arthritis with a combination of infliximab and azathioprine: one year results of an open pilot study [abstract]. Ann Rheum Dis 2002; FRI0140.
14. Kramer N, Chuzhin Y, Kaufman LD, Ritter JM, Rosenstein ED. Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2002;47:670-1.
15. Courtney PA. Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis. Arthritis Rheum 2003;49:617; author reply 617-8.
16. Dotan I, Yeshurun D, Hallak A, et al. Treatment of Crohn's disease with anti TNF alpha antibodies - the experience in the Tel Aviv Medical Center. Harefuah 2001;140:289-93,368.
17. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
18. Niden AH, Koss M, Boylen CT, et al. An open label pilot study to determine the potential efficacy of TNFR.FC (Enbrel®, etanercept) in the treatment of usual interstitial pneumonitis (UIP) [abstract]. Am J Respir Crit Care Med 2001:A25.
19. Peno-Green L, Lluberas G, Kingsley T, Brantley S. Lung injury linked to etanercept therapy. Chest 2002;122:1858-60.
20. Yousem SA, Dacic S. Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy. Mod Pathol 2005;18:651-5.
21. Vassallo R, Maltesen E, Thomas CF. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumour necrosis factor-α inhibition. Chest 2002;122:1093-6.
22. Cohen JM, Miller A, Spiera H. Interstitial pneumonitis complicating rheumatoid arthritis. Sustained remission with azathioprine therapy. Chest 1977;72:521-4.
23. Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 1994;7:515-8.
24. Miyazaki Y, Araki K, Vesin C, et al. Expression of a tumour necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis. J Clin Invest 1995;96:250-9.
25. Gosset P, Perez T, Lassalle P, et al. Increased TNF-α secretion by alveolar macrophages from patients with rheumatoid arthritis. Am Rev Respir Dis 1991;143:596-7.
26. Elias JA. Tumour necrosis factor interacts with interleukin 1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin dependent and independent mechanisms. Am Rev Respir Dis 1988;13:652-8.
27. Choy ESH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.